Sample preservation is a cornerstone of reproducible science. Whether you’re running a western blot, setting up a cell-based assay, or performing immunohistochemistry, sample integrity matters. A lot. While freezing slows processes, it doesn’t halt biology completely.

In this article, we’ll explore how samples change over time, how antibody-based assays can help you spot those changes, and what you can do to keep your samples in top shape.

Why sample quality is more than a storage label

Every sample tells a story. But if that story gets distorted, by degradation, oxidation, or repeated freeze-thaw cycles, it can lead you down the wrong path. That’s why sample preservation isn’t just a technical detail. It’s a foundation for reproducible, reliable science¹.

When samples degrade, proteins can unfold or clump together. RNA might fragment. Even subtle shifts in post-translational modifications can throw off your results^2,3. And if you’re working with rare or irreplaceable samples – like patient biopsies or longitudinal cohort collections – there’s no second chance.

What’s really going on in the freezer?

Freezing is a powerful preservation tool, but it’s not magic. When water inside a sample turns to ice, it can damage cells and denature proteins. The speed of freezing, the use of cryoprotectants, and the storage temperature all play a role in how well your sample survives⁴.

At –80°C or in liquid nitrogen, most enzymatic activity stops. But some slow processes, like oxidation or hydrolysis, can still creep in over time. And every time you thaw and refreeze a sample, you increase the risk of damage. That’s why minimizing freeze-thaw cycles is one of the golden rules of sample handling⁵.

How antibody-based assays help you see what’s changed

Antibodies are incredibly sensitive tools. They don’t just detect proteins. They can reveal how those proteins have changed. That makes them ideal for checking sample quality.

Let’s say you’re using a western blot. If your target protein shows a weaker signal than expected, it might be degraded or its epitope might be masked. In immunohistochemistry, patchy staining could point to tissue damage or poor fixation. And in a cell-based assay, reduced responsiveness might reflect compromised cell health.

Because antibodies are so specific, they can help you catch these issues early, before they affect your data. And when you use recombinant antibodies, you get consistent performance across batches, which is especially helpful for long-term studies.

Smart storage starts with good habits

Keeping your samples in good condition doesn’t have to be complicated. A few simple practices can go a long way:

1.      Store samples at the right temperature. For most proteins and nucleic acids, –80°C is a solid choice. For long-term storage of cells or tissues, liquid nitrogen is even better.

2.      Avoid freeze-thaw cycles. Aliquot your samples into single-use volumes so you don’t have to thaw the whole batch every time.

3.      Use cryoprotectants when needed. For cells and tissues, agents like DMSO or glycerol help prevent ice damage.

4.      Label everything clearly. Include the sample type, date, and any processing steps. Good metadata is just as necessary as the sample itself.

5.      Check your samples periodically. Use antibody-based assays to monitor stability over time. It’s a simple way to catch problems before they affect your results.

To learn more about good lab practices, check out our detailed antibody storage guide and step-by-step protocols.

Biobanking: more than just cold storage

Biobanks are like libraries for biological samples. But instead of books, they store tissues, blood, DNA, and more – along with detailed records of how each sample was collected, processed, and stored⁶.

High-quality biobanking isn’t just about keeping things cold. It’s about consistency, traceability, and quality control. And for researchers using biobank samples, knowing how those samples were handled is key. Were they snap-frozen or fixed? How long have they been stored? Have they been thawed before?

These details can influence everything from antibody binding to assay sensitivity. So when you’re working with biobank samples, ask questions. The answers matter.

What’s next in sample preservation?

As science moves faster and becomes more collaborative, the need for reliable, long-term sample storage is growing. And the tools are evolving to meet that need.

Lyophilization (freeze-drying) is being explored as a way to store proteins and antibodies at room temperature⁷. Stabilizing agents are being developed to protect fragile molecules like RNA and phosphoproteins⁸. Digital tracking systems are also helping labs monitor freezer conditions in real time⁹.

There’s also a growing interest in pre-analytical quality control, using molecular markers to assess sample integrity before analysis. Antibody-based assays are a natural fit here, offering a fast, specific way to check for degradation or contamination¹⁰.

Why does it all come back to reproducibility?

Reproducibility isn’t just a buzzword, it’s the backbone of good science. And sample quality plays a huge role in that. Even well-designed experiments fail without reliable samples. Proper sample storage and the use of antibody-based assays safeguard data integrity and conclusions.

This is especially important in fields like biomarker discovery, where small differences in protein expression can have big implications, and drug development, where a cell-based assay might be used to screen hundreds of compounds. In both cases, sample quality isn’t optional - it’s essential.

Your freezer is more than storage; it’s a research time capsule. While it slows biological change, it can’t stop it entirely. Be proactive: store samples wisely, use antibody-based assays for monitoring, and ask questions about your protocols or incoming samples. A little curiosity greatly impacts sample integrity.

Related resources

References

1.      Singh, S. K. Freezing of Proteins and Cells. In: Parenteral Medications, 4th ed (ed. Banker, G. S.) 27 (CRC Press, 2019).

2.      Shi, M. & McHugh, K. J. Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems.  Adv. Drug Deliv. Rev.  199, 114904 (2023).

3.      Aarum, J.  et al.  Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates.  EMBO Rep.  21, e49585 (2020).

4.      Murray, K. A. & Gibson, M. I. Chemical approaches to cryopreservation.  Nat. Rev. Chem.  6, 579–593 (2022).

5.      Prentø, P. The effects of freezing, storage, and thawing on cell compartment integrity and ultrastructure.  Histochem. Cell Biol.  108, 543–547 (1997).

6.      Annaratone, L.  et al.  Basic principles of biobanking: from biological samples to precision medicine for patients.  Virchows Arch.  479, 233–246 (2021).

7.      Kommineni, N.  et al.  Freeze-drying for the preservation of immunoengineering products.  iScience  25, 105127 (2022).

8.      Xian, H.  et al.  Nanobiotechnology-enabled mRNA stabilization.  Pharmaceutics  15, 620 (2023).

9.      Powell, S.  et al.  Real-time temperature mapping in ultra-low freezers as a standard quality assessment.  Biopreserv. Biobank.  17, 139–142 (2019).

10. Sotoudeh Anvari, M.  et al.  Pre-analytical practices in the molecular diagnostic tests, a concise review.  Iran. J. Pathol.  16, 1–19 (2021).